Twist Bioscience
Synthetic biology company providing synthetic DNA-based products using a proprietary silicon-based DNA synthesis platform. Publicly traded on NASDAQ (TWST). Serves healthcare, agriculture, industrial chemicals, and data storage markets.
Notes
Twist Bioscience is a synthetic biology company that provides synthetic DNA-based products for various industries including healthcare, agriculture, industrial chemicals, and data storage. The company is publicly traded on NASDAQ under the ticker symbol TWST and is headquartered in South San Francisco, California.
Twist's proprietary silicon-based DNA synthesis platform enables high-throughput, low-cost production of synthetic DNA. The company's products and services include:
- Gene synthesis
- Oligo pools
- NGS target enrichment
- Antibody discovery
- DNA data storage
- Biopharma services
The company's technology has enabled significant cost reductions in DNA synthesis, making synthetic biology more accessible to researchers and companies.
Team
- Emily Leproust, Ph.D. - Co-founder & Chief Executive Officer
- LinkedIn: linkedin.com/in/emilyleproust
- Bill Banyai, Ph.D. - Co-founder
- Bill Peck - Co-founder
Additional Research Findings
- NASDAQ: TWST (publicly traded since 2018 IPO)
- Silicon-based DNA synthesis platform
- Backed by Foresite Capital
- DNA synthesis for research, therapeutics, diagnostics
- High-throughput oligo synthesis technology
- South San Francisco, California headquarters
- Founded in 2013
- DNA data storage capabilities
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Foresite Capital | San Francisco, USA | biotech-focused | series-aseries-b+2 | 3 |
| OMX Ventures | San Francisco, California, USA | biotech-focused | seedseries-a | 23 |